Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2000
NCT00004978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Alternative names

Hospital Jose Maria Ramos Mejia

Active Ingredients

Drugs in Phase 3 Trials (1)

aldesleukin (Proleukin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1